The effect of abdominal massage on gastrointestinal functio

Phase 2

• Conditions: Condition 1: coma. Condition 2: Brain tumor. Condition 3: Head trauma. Condition 4: Malignant Brain tumor. Condition 5: Acute respiratory failure.; Coma?Unspecified; Benign neoplasm of brain and other parts of central nervous system; Post- concussional syndrome; Malignant neoplasm of brain; Respiratory failure, not elsewhere classified

• Registration Number: IRCT2017030531972N2
• Lead Sponsor: Vice Chancellor for Research of Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Over age 18 years up to 70ears; nutrition by nose-feed tube to enteral feeding alternative methods; have not received metoclopramide, erythromycin, cisapride, and anticholinergic agents; have not received radiotherapy treatment and surgery on the abdominal region in the previous 6 weeks; have no contraindication to abdominal massage for examples: cellulitis, abdominal mass, peritonitis, abdominal aneurysm, ascites (Recognizing doctor), consciousness (GCS) less than 9.
Exclusion criteria: having vomiting (view the contents reflux regardless of its value) (vomiting increase the risk of aspiration effect); NPO for doing laboratory tests and surgical procedures; incidence diarrhea (having 3 or more loose stools per day times the volume More200-250 cc); discharge from ICU or death less than 3 days; hyperglycemia (blood sugar more than 200) and hypokalemia (potassium level less than3/5); GI bleeding (Recognizing doctor); patientes be extubated before 3 day; patients who have aspiration Before entering the study; patientes because of severe trauma have is not been able to get on the suitable position for massage; patientes have spinal cord injury?; incidence ascites during the study.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Constipation. Timepoint: end three day. Method of measurement: not defecation during three day.;Distention. Timepoint: first day and last day. Method of measurement: by measurement circumference abdoman.;Defecation. Timepoint: daily. Method of measurement: number defecation.;Gastric residual volume. Timepoint: before every feeding. Method of measurement: with 50 cc feeding syring.;Aspiration. Timepoint: end three day. Method of measurement: determination airway secretion PH and glucose.